---
title: "Takayasu arteritis clinical issues"
---
-Early phase inflammatory or prepulseless phase.
-Late phase occlusive or pulseless.
-Age &lt; 30 in 90% of patients.
-Gender: M:F = 1:8.
-Morbidity and mortality due to HTN and stroke.
-Corticosteroids are mainstay of therapy.

